Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWolf Minerals Regulatory News (WLFE)

  • There is currently no data for WLFE

Offtake agreements

20 Apr 2012 08:35

RNS Number : 7423B
Wolf Minerals Limited
20 April 2012
 



20 April 2012

 

Wolf signs tungsten offtake deal

 

 

Wolf Minerals Limited ("Wolf") is pleased to announce that the Company has signed a non-binding Heads of Terms ("Heads") for tungsten offtake and a loan facility with Wolfram Bergbau und Hutten AG, Austria ("WBH"), and Global Tungsten & Powders Corp, Pennsylvania, USA ("GTP"). These agreements are part of a joint effort between WBH and GTP to support the development of a new major tungsten mine.

 

These offtake agreements cover 80% of Hemerdon's expected average annual tungsten concentrate output for a period of a minimum of 5 years, extendable under mutual consent. Under the Heads Wolf is expected to supply a 65% tungsten trioxide, wolframite concentrate based upon standard commercial terms. The Hemerdon mine is expected to produce an average of 345,000 mtu's of tungsten trioxide in concentrates per annum and 450 tonnes of tin.

 

Subject to technical and legal due-diligence as well as board approvals WBH and GTP will provide a £20 million loan facility to Wolf. This will form part of the project funding package and is in addition to the recently announced debt facility of £55 million.

 

Wolf expects to complete the final documentation for the offtake agreements, in conjunction with documentation for the lending banks, in the second quarter of 2012.

 

Humphrey Hale, CEO, commented "The signing of a long term offtake contract with two of the largest tungsten producers represents a significant milestone in the development of the Hemerdon tungsten mine. The company is pleased to provide security of supply to these global specialty powder and metal manufacturers and looks forward to developing a strong relationship in the future."

 

ENDS

 

 

 

For further details, please contact:

 

Wolf Minerals Limited

Humphrey Hale

 

+61 8 6364 3776

Investec

Mark Wellesley-Wood/Neil Elliot

+44 20 7597 4000

 

Newgate Threadneedle

Josh Royston/Beth Harris

+44 (0) 20 7653 9850

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDBLBLLZFXBBX
Date   Source Headline
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:01 amRNSAppendix 3Y
30th Jun 20177:01 amRNSIssue of Equity and Change of Directors' Interests
29th Jun 20179:15 amRNSReplacement of Grant of ASX Listing Rule Waivers
28th Jun 20173:15 pmRNSASX Listing Waivers for Bridge Facility Increase
28th Jun 20173:15 pmRNSBridge Facility with RCF Increased
16th Jun 20177:00 amRNSIssue of Equity
16th Jun 20177:00 amRNSAppendix 3B
16th May 20177:00 amRNSCancellation of Lapsed Performance Rights
15th May 20179:05 amRNSAppendix 3Z
15th May 20179:05 amRNSResignation of Director
8th May 20177:00 amRNSAppendix 3X
8th May 20177:00 amRNSInterim MD, Richard Lucas, Appointed to Wolf Board
28th Apr 20177:00 amRNSAppendix 5B
28th Apr 20177:00 amRNSQuarterly Activities Report
7th Apr 201710:19 amRNSDirectorate Change
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSIssue of Equity and Change of Directors' Interests
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSCleansing Notice Letter
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3B
4th Apr 20177:00 amRNSAppendix 3Y
16th Mar 20177:02 amRNSInterim Financial Statements
13th Mar 20177:35 amRNSUpdate on Bridge Facility with RCF
20th Feb 20174:41 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
10th Feb 20179:20 amRNSCancellation of Lapsed Performance Rights
6th Feb 20177:00 amRNSRevised Securities Dealing Policy
31st Jan 20177:00 amRNSAppendix 5B
31st Jan 20177:00 amRNSQuarterly Activities Report
30th Dec 20168:10 amRNSCleansing Notice Letter
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3B
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:09 amRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20161:15 pmRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.